Provided by Tiger Trade Technology Pte. Ltd.

DiaMedica Therapeutics Inc.

8.42
-0.0800-0.94%
Volume:180.63K
Turnover:1.51M
Market Cap:451.13M
PE:-11.76
High:8.49
Open:8.39
Low:8.10
Close:8.50
52wk High:10.42
52wk Low:3.19
Shares:53.58M
Float Shares:32.94M
Volume Ratio:0.99
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7162
EPS(LYR):-0.6050
ROE:-64.12%
ROA:-38.33%
PB:8.74
PE(LYR):-13.92

Loading ...

Jan Stahlberg, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Sep 05, 2025

DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02, 2025

DiaMedica Therapeutics Inc - May Sell Common Shares up to $100 Mln - SEC Filing

THOMSON REUTERS
·
Aug 13, 2025

DiaMedica Therapeutics Signs $100 Million Sales Agreement with TD Cowen for At-the-Market Offering

Reuters
·
Aug 13, 2025

DiaMedica Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13, 2025

DiaMedica Therapeutics Q2 Pretax Profit USD -7.693 Million

THOMSON REUTERS
·
Aug 13, 2025

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Aug 09, 2025

DiaMedica Therapeutics Appoints Julie Krop, Md, as Chief Medical Officer

THOMSON REUTERS
·
Aug 06, 2025

BRIEF-Diamedica Therapeutics To Report Second Quarter 2025 Financial Results And Provide A Business Update August 13, 2025

Reuters
·
Aug 06, 2025

DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025

THOMSON REUTERS
·
Aug 06, 2025

DiaMedica Therapeutics Inc Files for Resale of up to 8.6 Mln Common Shares by the Selling Shareholders - SEC Filing

THOMSON REUTERS
·
Aug 01, 2025

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Aug 01, 2025

Jan Stahlberg, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26, 2025

Thomas Von Koch, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26, 2025

Richard Jacinto II Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26, 2025

DiaMedica Therapeutics Closes $30.1 Million Private Placement to Advance Clinical-Stage Biopharmaceutical Initiatives

Reuters
·
Jul 24, 2025

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement

THOMSON REUTERS
·
Jul 24, 2025

DiaMedica Therapeutics to Raise $30 Million Via Private Placement

MT Newswires Live
·
Jul 21, 2025